← FDA Drug Approvals (Drugs@FDA)

TIGECYCLINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: XELLIA PHARMS APS · Approved 2019-10-18

Drug application

FDA Application #

ANDA205722

Application type

Abbreviated New Drug Application (Generic)

Brand name

TIGECYCLINE

Generic name

Tigecycline

Active ingredients

TIGECYCLINE

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

XELLIA PHARMS APS

First approval

2019-10-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown